Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial.

DOI:10.1016/S0140-6736(15)00447-X
作者：Michael Haude,?Hüseyin Ince,?Alexandre Abizaid,?Ralph Toelg,?Pedro Alves Lemos,?Clemens von Birgelen,?Evald H?j Christiansen,?William Wijns,?Franz-Josef Neumann,?Christoph Kaiser,?Eric Eeckhout,?Soo
文献类型：期刊论文
补充材料：只需要正文